# US 2015/0148525 A1 · Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0148525 A1
- Document ID: US20150148525A1
- Status: Published application
- Kind: A1
- Application number: 14/401,803
- Filed: 2013-05-15
- Published: 2015-05-28
- Earliest claimed: 2012-05-18
- Assignees: Medical Research Council
- Applicants: Medical Research Council
- Inventors: Jason Chin; Kathrin Lang
- Web page: https://patentgrep.com/patent/US20150148525A1

## CPC

- C07K 1/006: {of peptides containing derivatised side chain amino acids}
- C07C 271/22: to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07K 1/13: Labelling of peptides
- C07K 2/00: Peptides of undefined number of amino acids; Derivatives thereof
- C12N 9/93: {Ligases (6)}
- C12Y 601/01026: Pyrrolysine-tRNAPyl ligase (6.1.1.26)
- G01N 33/582: {with fluorescent label}
- C07C 2602/24: the ring system containing nine carbon atoms, e.g. perhydroindane
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to a polypeptide comprising an amino acid having a bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN) group, particularly when said BCN group is present as: a residue of a lysine amino acid. The invention also relates to a method of producing a polypeptide comprising a BCN group, said method comprising genetically incorporating an amino acid comprising a BCN group into a polypeptide. The invention also relates to an amino acid comprising bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN), particularly and amino acid which is bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN) lysine. In addition the invention relates to a PylRS tRNA synthetase comprising the mutations Y271M, L274G and C313A.

## Claims

### Claim 1

A polypeptide comprising an amino acid having a bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN) group.

### Claim 2 (depends on 1)

A polypeptide according to claim 1 wherein said BCN group is present as a residue of a lysine amino acid.

### Claim 3

A method of producing a polypeptide comprising a BCN group, said method comprising genetically incorporating an amino acid comprising a BCN group into a polypeptide.

### Claim 4 (depends on 3)

A method according to claim 3 wherein producing the polypeptide comprises
(i) providing a nucleic acid encoding the polypeptide which nucleic acid comprises an orthogonal codon encoding the amino acid having a BCN group;
(ii) translating said nucleic acid in the presence of an orthogonal tRNA synthetase/tRNA pair capable of recognising said orthogonal codon and incorporating said amino acid having a BCN group into the polypeptide chain.

### Claim 5 (depends on 3)

A method according to claim 3 wherein said amino acid comprising a BCN group is a BCN lysine.

### Claim 6 (depends on 4)

A method according to claim 4 wherein said orthogonal codon comprises an amber codon (TAG), said tRNA comprises MbtRNACUA, said amino acid having a BCN group comprises a bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN) lysine and said tRNA synthetase comprises a PylRS synthetase having the mutations Y271M, L274G and C313A (BCNRS).

### Claim 7 (depends on 1, 3, 4, 5, 6)

A polypeptide according to claim 1, or a method according to any of claims 3 to 6, wherein said amino acid having a BCN group is incorporated at a position corresponding to a lysine residue in the wild type polypeptide.

### Claim 8 (depends on 1)

A polypeptide according to claim 1 which comprises a single BCN group.

### Claim 9 (depends on 1)

A polypeptide according to claim 1 wherein said BCN group is joined to a tetrazine group.

### Claim 10 (depends on 9)

A polypeptide according to claim 9 wherein said tetrazine group is further joined to a fluorophore.

### Claim 11 (depends on 10)

A polypeptide according to claim 10 wherein said fluorophore comprises fluorescein, tetramethyl rhodamine (TAMRA) or boron-dipyrromethene (BODIPY).

### Claim 12

An amino acid comprising bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN).

### Claim 13 (depends on 12)

An amino acid according to claim 12 which is bicyclo[6.1.0]non-4-yn-9-ylmethanol (BCN) lysine.

### Claim 14 (depends on 13)

BCN lysine according to claim 13 having the structure:

### Claim 15 (depends on 1)

A method of producing a polypeptide comprising a tetrazine group, said method comprising providing a polypeptide according to claim 1, contacting said polypeptide with a tetrazine compound, and incubating to allow joining of the tetrazine to the BCN group by an inverse electron demand Diels-Alder cycloaddition reaction.

### Claim 16 (depends on 15)

A method according to claim 15 wherein the tetrazine is selected from 6 to 17 of FIG. 1.

### Claim 17 (depends on 15)

A method according to claim 15 wherein the tetrazine is selected from 6, 7, 8 and 9 of FIG. 1 and the pseudo first order rate constant for the reaction is at least 80 M−1 s−1.

### Claim 18 (depends on 15)

A method according to claim 15 wherein said reaction is allowed to proceed for 10 minutes or less.

### Claim 19 (depends on 18)

A method according to claim 18 wherein said reaction is allowed to proceed for 1 minute or less.

### Claim 20 (depends on 19)

A method according to claim 19 wherein said reaction is allowed to proceed for 30 seconds or less.

### Claim 21 (depends on 15)

A method according to claim 15 wherein said tetrazine compound is a tetrazine compound selected from the group consisting of 11 and 17 of FIG. 1.

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24

(canceled)
